Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.62 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.62 |
| ▸ | IPMK | Q8NFU5 | 4/20 | 0.62 |
| ▸ | IP6K2 | Q9UHH9 | 4/20 | 0.62 |
| ▸ | CA12 | O43570 | 4/20 | 0.62 |
| ▸ | CA2 | P00918 | 4/20 | 0.62 |
| ▸ | CA7 | P43166 | 4/20 | 0.62 |
| ▸ | XDH | P47989 | 4/20 | 0.62 |
| ▸ | CA4 | P22748 | 3/20 | 0.62 |
| ▸ | PPARG | P37231 | 3/20 | 0.62 |
| ▸ | NOX4 | Q9NPH5 | 3/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.56 |
| ▸ | MAOA | P21397 | 4/20 | 0.56 |
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 8/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Curcumin SCHEMBL20291461 | 0.95 | MEN1 (0.68) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL8442487 | 0.87 | MEN1 (0.70) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Isorhamnetin SCHEMBL3715283 | 0.81 | MEN1 (0.93) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL15227652 | 0.80 | POLH (0.58) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Kaempferol SCHEMBL4381859 | 0.80 | MEN1 (0.74) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL8442485 | 0.80 | POLH (0.64) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Isorhamnetin SCHEMBL28182051 | 0.79 | MEN1 (0.93) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Kaempferol SCHEMBL17515073 | 0.79 | CYP1A2 (0.78) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Curcumin SCHEMBL2303947 | 0.79 | ABCB1 (0.90) | MEN1KMT2ACYP1A2CA12CA2 | |
| Isorhamnetin SCHEMBL19235 | 0.78 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11234942-B2 | Composition and method for inhibiting platelet aggregation | KNEPPER PAUL A (US) | 2022-02-01 | — | — | US | disclosed |
| US-20190175522-A1 | COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION | KNEPPER PAUL A (US) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234942-B2 | Composition and method for inhibiting platelet aggregation | TLR4, TLR2, PTGER2 | MEN1 2857/4885KMT2A 2586/4885CYP1A2 1149/4885 |
| US-20190175522-A1 | COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION | TLR4, TLR2, PTGER2 | MEN1 2857/4885KMT2A 2586/4885CYP1A2 1149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.